story of the week
Trastuzumab Duocarmazine in Locally Advanced and Metastatic HER2-Expressing Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Duocarmazine in Locally Advanced and Metastatic Solid Tumours and HER2-Expressing Breast Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
Lancet Oncol 2019 Jun 27;[EPub Ahead of Print], U Banerji, CML van Herpen, C Saura, F Thistlethwaite, S Lord, V Moreno, IR Macpherson, V Boni, C Rolfo, EGE de Vries, S Rottey, J Geenen, F Eskens, M Gil-Martin, EC Mommers, NP Koper, P AftimosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.